Chinese medical authorities claim that a drug used in Japan to treat new strains of influenza seems effective for coronavirus patients, Japanese media has reported.
Zhang Xinmin, an official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.
Patients who were given the medicine in Shenzhen turned negative for the virus after a median of four days after becoming positive, compared with a median of 11 days for those who were not treated with the drug.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.
If media is to become a credible source, it should provide reliable and accurate information, and has to work with utmost diligence to offer reports and comments objectively.
Newsmakers - a platform where you find not only news but also the facts behind it; where you read not only analysis based on facts but also blogs written by people having different opinions. Our objective is to make news even more interesting for you. We believe in freedom of expression but with responsibility. Long Live Pakistan